Company overview
USCC
91360733MA38AMFT7K
Id2
-
English Name
Ganzhou Maoyuan Pharmaceutical Co., Ltd.
Former names
-
Chinese Name
赣州茂源药业有限公司
Entity type
Limited Liability Company (Natural Person Invested or Controlled)
Authorized capital
¥30,000
Phone
+8618006792333
Representative
吕承
Establishment date
21 December 2018
Country
China
Primary goods traded
| Data Source | HS Code | Description | Buyer | Buyer Country | Seller | Seller Country | ||
|---|---|---|---|---|---|---|---|---|
| 10 November 2023 | ID | 29182300 | Methyl Salicylate - | PT Eagle Indo Pharma | ID | Ganzhou Maoyuan Pharmaceutical Company Limited | $121,200.00 | |
| 19 May 2025 | ID | 29182300 | Benzyl Salicylate | PT Mane Indonesia | ID | Ganzhou Maoyuan Pharmaceutical Company Limited | $92,160.00 | |
| 6 September 2023 | ID | 29182300 | Methyl Salicylate - | PT Eagle Indo Pharma | ID | Ganzhou Maoyuan Pharmaceutical Company Limited | $80,800.00 | |
| 4 August 2023 | ID | 29182300 | Methyl Salicylate - | PT Eagle Indo Pharma | ID | Ganzhou Maoyuan Pharmaceutical Company Limited | $80,800.00 | |
| 12 October 2023 | ID | 29182300 | Methyl Salicylate - | PT Eagle Indo Pharma | ID | Ganzhou Maoyuan Pharmaceutical Company Limited | $80,800.00 | |
| 6 December 2024 | ID | 29182300 | Methyl Salicylate | PT Eagle Indo Pharma | ID | Ganzhou Maoyuan Pharmaceutical Company Limited | $73,200.00 | |
| 19 November 2024 | ID | 29182300 | Methyl Salicylate | PT Eagle Indo Pharma | ID | Ganzhou Maoyuan Pharmaceutical Company Limited | $73,200.00 | |
| 8 October 2024 | ID | 29182300 | Methyl Salicylate | PT Eagle Indo Pharma | ID | Ganzhou Maoyuan Pharmaceutical Company Limited | $73,200.00 | |
| 10 June 2024 | ID | 29182300 | Methyl Salicylate - | PT Eagle Indo Pharma | ID | Ganzhou Maoyuan Pharmaceutical Company Limited | $73,200.00 | |
| 6 December 2024 | ID | 29182300 | Methyl Salicylate | PT Eagle Indo Pharma | ID | Ganzhou Maoyuan Pharmaceutical Company Limited | $73,200.00 |
| Partner | Type | Total Value | Percentage |
|---|---|---|---|
| PT Eagle Indo Pharma | buyer | $879,800 | 81.50% |
| Unknown | buyer | $199,728 | 18.50% |